Abstract:Background: We aimed to develop and validate a radiomics signature based on pretreatment MRI images to predict a good response (GR) to neoadjuvant chemotherapy (nCRT) in patients with locally advanced rectal cancer (LARC) and to research its prognostic value in predicting distant metastasis.Methods: A total of 922 patients with LARC were retrospectively recruited from 3 Chinese hospitals between Dec 1, 2009, and Jan 30, 2018. The training dataset was comprised of 509 patients from centre I; external validation dataset 1 (EVD1) was comprised of 242 patients from centre II; and EVD2 was comprised of 171 patients from centre III. The radiomics features were extracted from the T2WI and ADC images. A three-step procedure, including the least absolute shrinkage and selection operator (LASSO) algorithm, minority oversampling technique (SMOTE) and support vector machine (SVM) classifier, was applied for feature selection and signature building. The prediction performance was evaluated using the area under the curve (AUC), accuracy, sensitivity and specificity. A nomogram integrating the radiomics signature and clinical-MRI features to predict distant metastasis (DM) was constructed.Findings: Nineteen, 3, and 22 radiomic features were selected in the T2WI-based, ADC-based, and fusion models for GR prediction, respectively. Among the three models, the fusion model showed satisfactory discrimination of GR to nCRT and yielded AUCs of 0.89±0.02 (95% CI, 0.87−0.92), 0.69±0.05 (95% CI, 0.61−0.78), and 0.72±0.04 (95% CI, 0.65−0.79) in the training and two external validation datasets, respectively. In addition, the combined nomogram was successfully built with AUCs of 0.69, 0.78 and 0.66 in the three datasets. Kaplan‒Meier curves of disease-free survival(DFS) between the high-risk and low-risk DM patients who were grouped by the nomogram showed statisticalsignificance with p<0.05 in the three datasets.Interpretation:The MRI-based radiomics signature exhibited promising performance for response prediction to nCRT in LARC patients and can also provide prognostic value for DM prediction, which may assist in individualized clinical treatment.Funding Information: This study was supported by the National Natural Science Foundation of China (No. 82001776, 81971687, 82271946), Shanghai AntiCancer Association Young Eagle Program (SACA-CY20C130),Shanghai Natural Science Foundation (No. 20ZR1412700). Declaration of Interests: All authors declare no competing interests. Ethics Approval Statement: This retrospective multicentre study was conducted in accordance with the Declaration of Helsinki. Ethics approval was obtained from the Institutional Review Board of all participating centres, and the requirement for informed consent was waived due to the retrospective nature. A total of 509 consecutive patients with LARC were enrolled in Fudan University Shanghai Cancer Center (FUSCC) from 2016/05 to 2018/01; 171 consecutive patients from 2013/03 to 2016/11 were enrolled in Shanxi Cancer Hospital (SXPCH); and 242 consecutive patients from 2009/12 to 2015/05 were enrolled in Beijing Cancer Hospital (BJCH).

Role of microenvironment characteristics and MRI radiomics in the risk stratification of distant metastases in rectal cancer: A diagnostic study

Prognostic Prediction Value of the Clinical-Radiomics Tumour-Stroma Ratio in Locally Advanced Rectal Cancer

Predicting the risk of distant metastasis in patients with locally advanced rectal cancer using model based on pre-treatment T2WI-based radiomic features plus postoperative pathological stage

Prognostic risk factors and survival models for T3 locally advanced rectal cancer: what can we learn from the baseline MRI?

A study on multiparametric MRI-based radiomics approach to preoperatively estimating tumor-stroma ratio in rectal cancer

Radiomics of rectal cancer for predicting distant metastasis and overall survival

MRI-based Radiomics to Predict Neoadjuvant Chemoradiotherapy Outcomes in Locally Advanced Rectal Cancer: A Multicenter Study

Radiomics Signature Based on Support Vector Machines for the Prediction of Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

Prediction by a multiparametric magnetic resonance imaging-based radiomics signature model of disease-free survival in patients with rectal cancer treated by surgery

Effects of MRI radiomics combined with clinical data in evaluating lymph node metastasis in mrT1-3a staging rectal cancer

MRI-based Radiomics of Rectal Cancer: Preoperative Assessment of the Pathological Features

Magnetic resonance imaging-based radiomics analysis for prediction of treatment response to neoadjuvant chemoradiotherapy and clinical outcome in patients with locally advanced rectal cancer: A large multicentric and validated study

The Feasibility of MRI-based Radiomics Model in Presurgical Evaluation of Tumor Budding in Locally Advanced Rectal Cancer

Mri-Based Radiomics Signature for Predicting Response to Neoadjuvant Chemotherapy in Patients with Locally Advanced Rectal Cancer: A Multicentre Study

Prediction of pathological response and lymph node metastasis after neoadjuvant therapy in rectal cancer through tumor and mesorectal MRI radiomic features

Development and validation of magnetic resonance imaging- based radiomics models for preoperative prediction of microsatellite instability in rectal cancer

Multiparametric MRI-based Radiomics Signature for Preoperative Estimation of Tumor-Stroma Ratio in Rectal Cancer.

MRI-based multiregional radiomics for predicting lymph nodes status and prognosis in patients with resectable rectal cancer

MRI-based radiomics feature combined with tumor markers to predict TN staging of rectal cancer

Multiparametric MRI subregion radiomics for preoperative assessment of high-risk subregions in microsatellite instability of rectal cancer patients: A multicenter study